Incretin hormones and beta-cell mass expansion: what we know and what is missing?

References

• Abraham EJ, Leech CA, Lin JC, et al. (2002). Insulinotropic hormone glucagon like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin producing cells. Endocrinology, 143:3152–61
   PubMed Web of Science ®Google Scholar
• Agersø H, Jensen LB, Elbrønd B, et al. (2002). The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men. Diabetologia, 45:195–202
   PubMed Web of Science ®Google Scholar
• Ahren B, Carr RD, Deacon CF. (2010). Incretin hormone secretion over the day. Vitam Horm, 84:203–20
   PubMed Web of Science ®Google Scholar
• Ahren B. (2003). Gut peptides and type 2 diabetes mellitus treatment. Curr Diab Rep, 3:365–72
   PubMedGoogle Scholar
• Arakawa M, Ebato C, Mita T, et al. (2009). Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. Biochem Biophys Res Commun, 390:809–14
   PubMed Web of Science ®Google Scholar
• Arnette D, Gibson TB, Lawrence MC, et al. (2003). Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J Biol Chem, 278:32517–25
   PubMed Web of Science ®Google Scholar
• Baggio LL, Drucker DJ. (2007). Biology of incretins: GLP-1 andGIP. Gastroenterology, 132:2131–57
   PubMed Web of Science ®Google Scholar
• Bastien-Dionne PO, Valenti L, Kon N, et al. (2011). Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic β-cell mass expansion. Diabetes, 60:3217–22
   PubMed Web of Science ®Google Scholar
• Bocker D, Verspohl EJ. (2001). Role of protein kinase C, PI3-kinase and tyrosine kinase in activation of MAP kinase by glucose and agonists of G-protein coupled receptors in INS-1 cells. Int J Exp Diabetes Res, 2:233–44
   PubMedGoogle Scholar
• Bonner-Weir S. (2000). Life and death of the pancreatic beta cells. Trends Endocrinol Metab, 11:375–8
   PubMed Web of Science ®Google Scholar
• Bonner-Weir S, Weir GC. (2005). New sources of pancreatic beta-cells. Nat Biotechnol, 23:857–61
   PubMed Web of Science ®Google Scholar
• Brennand K, Huangfu D, Melton D. (2007). All beta cells contribute equally to islet growth and maintenance. PLoS Biology, 5:e163
   PubMed Web of Science ®Google Scholar
• Brissova M, Fowler MJ, Nicholson WE, et al. (2005). Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem, 53:1087–97
   PubMed Web of Science ®Google Scholar
• Brüning JC, Winnay J, Bonner-Weir S, et al. (1997). Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell, 88:561–72
   PubMed Web of Science ®Google Scholar
• Buse JB, Rosenstock J, Sesti G, et al; LEAD-6 Study Group. (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). The Lancet, 374:39–47
   PubMed Web of Science ®Google Scholar
• Buteau J, Foisy S, Joly E, Prentki M. (2003). Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes, 52:124–32
   PubMed Web of Science ®Google Scholar
• Buteau J, El-Assaad W, Rhodes CJ, et al. (2004). Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia, 47:806–15
   PubMed Web of Science ®Google Scholar
• Butler AE, Janson J, Bonner-Weir S, et al. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 52:102–10
   PubMed Web of Science ®Google Scholar
• Cabrera O, Berman DM, Kenyon NS, et al. (2006). The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA, 103:2334–9
   PubMed Web of Science ®Google Scholar
• Cano DA, Rulifson IC, Heiser PW, et al. (2008). Regulated β-cell regeneration in the adult mouse pancreas. Diabetes, 57:958–66
   PubMed Web of Science ®Google Scholar
• Chae HY, Kang JG, Kim CS, et al. (2012). Effect of glucagon-like peptide-1 gene expression on graft function in mouse islet transplantation. Transpl Int, 25:242–9
   PubMed Web of Science ®Google Scholar
• Chia CW, Egan JM. (2008). Incretin-based therapies in type 2 diabetes mellitus. J Clin Endocrinol Metab, 93:3703–16
   PubMed Web of Science ®Google Scholar
• Cho H, Mu J, Kim JK, et al. (2001). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science, 292:1728–31
   PubMed Web of Science ®Google Scholar
• Chung CH, Hao E, Piran R, et al. (2010). Pancreatic β-cell neognesis by direct conversion from mature α-cells. Stem Cells, 28:1630–38
   PubMed Web of Science ®Google Scholar
• Cnop M, Welsh N, Jonas JC, et al. (2005). Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes, 54:S97–107
   PubMed Web of Science ®Google Scholar
• Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, et al. (2006). Molecular control of cell cycle progression in the pancreatic β-cell. Endocr Rev, 27:356–70
   PubMed Web of Science ®Google Scholar
• Cunha DA, Ladrière L, Ortis F, et al. (2009). Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes, 58:2851–62
   PubMed Web of Science ®Google Scholar
• D’Amico E, Hui H, Khoury N, et al. (2005). Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs. J Mol Endocrinol, 34:377–90
   PubMed Web of Science ®Google Scholar
• Deacon CF, Johnsen AH, Holst JJ. (1995a). Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab, 80:952–7
   PubMed Web of Science ®Google Scholar
• Deacon CF, Nauck MA, Toft-Nielsen M, et al. (1995b). Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes, 44:1126–31
   PubMed Web of Science ®Google Scholar
• Deacon CF, Ahrén B. (2011). Physiology of incretins in health and disease. Rev Diabet Stud, 8:293–306
   PubMedGoogle Scholar
• Del Guerra S, Lupi R, Marselli L, et al. (2005). Functional and molecular alterations of pancreatic islets in human Type 2 diabetes. Diabetes, 54:727–35
   PubMed Web of Science ®Google Scholar
• Donath MY, Halban PA. (2004). Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia, 47:581–9
   PubMed Web of Science ®Google Scholar
• Donath MY, Ehses JA, Maedler K, et al. (2005). Mechanisms of beta-cell death in type 2 diabetes. Diabetes, 54:S108–13
   PubMed Web of Science ®Google Scholar
• Dor Y, Brown J, Martinez OI, Melton DA. (2004). Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature, 429:41–6
   PubMed Web of Science ®Google Scholar
• Dor Y, Melton DA. (2008). Facultative endocrine progenitor cells in the adult pancreas. Cell, 132:183–4
   PubMed Web of Science ®Google Scholar
• Drucker DJ, Philippe J, Mojsov S, et al. (1987). Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA, 84:3434–8
   PubMed Web of Science ®Google Scholar
• Drucker DJ. (2002). Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology, 122:531–44
   PubMed Web of Science ®Google Scholar
• Dunlop M, Muggli E, Clark S. (1996). Association of cyclin-dependent kinase-4 and cyclin D1 in neonatal β cells after mitogenic stimulation by lysophosphatidic acid. Biochem Biophys Res Commun, 218:132–6
   PubMed Web of Science ®Google Scholar
• Ebato C, Uchida T, Arakawa M, et al. (2008). Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab, 8:325–32
   PubMed Web of Science ®Google Scholar
• Ehses JA, Pelech SL, Pederson RA, McIntosh CH. (2002). Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMPdependent protein kinase/Rap1-mediatedpathway. J Biol Chem, 277:37088–97
   PubMed Web of Science ®Google Scholar
• Ehses JA, Casilla VR, Doty T, et al. (2003). Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogenactivated protein kinase. Endocrinology, 144:4433–45
   PubMed Web of Science ®Google Scholar
• Elliott RM, Morgan LM, Tredger JA, et al. (1993). Glucagon-like peptide-1 (7–36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol, 138:159–66
   PubMed Web of Science ®Google Scholar
• Elrick H, Stimmler L, Hlad Cj Jr, Arai Y. (1964). Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab, 24:1076–82
   PubMed Web of Science ®Google Scholar
• Farilla L, Hui H, Bertolotto C, et al. (2002). Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology, 143:4397–408
   PubMed Web of Science ®Google Scholar
• Fehmann HC, Goke R, Goke B. (1995). Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucosedependent insulin releasing polypeptide. Endocr Rev, 16:390–410
   PubMed Web of Science ®Google Scholar
• Friedrichsen BN, Neubauer N, Lee YC, et al. (2006). Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol, 188:481–92
   PubMed Web of Science ®Google Scholar
• Georgia S, Bhushan A. (2004). Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest, 114:963–8
   PubMed Web of Science ®Google Scholar
• Gepts W, Lecompte PM. (1981). The pancreatic islets in diabetes. Am J Med, 70:105–15
   PubMed Web of Science ®Google Scholar
• Gonzalez CD, Lee MS, Marchetti P, et al. (2011). The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy, 7:2–11
   PubMed Web of Science ®Google Scholar
• Gupta RK, Gao N, Gorski RK, et al. (2007). Expansion of adult β-cell mass in response to increasedmetabolic demand is dependent on HNF-4α. Genes Dev, 21:756–69
   PubMed Web of Science ®Google Scholar
• Halban PA. (2004). Cellular sources of new pancreatic beta-cells and therapeutic implications for regenerative medicine. Nat Cell Bio, 6:1021–5
   PubMed Web of Science ®Google Scholar
• Heit JJ, Apelqvist AA, Gu X, et al. (2006a). Calcineurin/NFAT signalling regulates pancreatic betA-cell growth and function. Nature, 443:345–9
   PubMed Web of Science ®Google Scholar
• Heit JJ, Karnik SK, Kim SK. (2006b). Intrinsic regulators of pancreatic beta-cell proliferation. Ann Rev Cell Dev Biol, 22:311–38
   PubMed Web of Science ®Google Scholar
• Herbach N, Bergmayr M, Göke B, et al. (2011). Postnatal development of numbers and mean sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice. PLoS One [Online] Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0022814. [last accessed 26 Jul 2011]
   Google Scholar
• Hui H, Wright C, Perfetti R. (2001). Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes, 50:785–96
   PubMed Web of Science ®Google Scholar
• Hui H, Perfetti R. (2002). Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol, 146:129–41
   PubMed Web of Science ®Google Scholar
• Hui H, Nourparvar A, Zhao X, Perfetti R. (2003). Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphatedependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology, 144:1444–55
   PubMed Web of Science ®Google Scholar
• Ichii H, Inverardi L, Pileggi A, et al. (2005). A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant, 5:1635–45
   PubMed Web of Science ®Google Scholar
• Igoillo-Esteve M, Marselli L, Cunha DA, et al. (2010). The inflammatory response of human pancreatic β-cells in type 2 diabetes is mimicked by in vitro exposure to palmitate. Diabetologia, 53:1395–405
   PubMed Web of Science ®Google Scholar
• Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. (2007). Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA, 104:15069–74
   PubMed Web of Science ®Google Scholar
• Jung HS, Lee MS. (2009). Macroautophagy in homeostasis of pancreatic β-cell. Autophagy, 5:241–3
   PubMed Web of Science ®Google Scholar
• Kashima Y, Miki T, Shibasaki T, et al. (2001). Critical role of cAMP-GEFII–Rim2 complex in incretinpotentiated insulin secretion. J Biol Chem, 276:46046–53
   PubMed Web of Science ®Google Scholar
• Kim SJ, Winter K, Nian C, et al. (2005). Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem, 280:22297–307
   PubMed Web of Science ®Google Scholar
• Kim SJ, Nian C, Widenmaier S, McIntosh CH. (2008). Glucose-dependent insulinotropic polypeptide mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2. Mol Cell Biol, 28:1644–56
   PubMed Web of Science ®Google Scholar
• Kolterman OG, Kim DD, Shen L, et al. (2005). Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm, 62:173–81
   PubMed Web of Science ®Google Scholar
• Knudsen LB, Nielsen PF, Huusfeldt PO, et al. (2000). Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J Med Chem, 43:1664–9
   PubMed Web of Science ®Google Scholar
• Kubota A, Yamada Y, Yasuda K, et al. (1997). Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways. Biochem Biophys Res Commun, 235:171–5
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Jhala US, Winnay JN, et al. (2004). PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest, 114:828–36
   PubMed Web of Science ®Google Scholar
• Kwon G, Pappan KL, Marshall CA, et al. (2004). cAMP dose-dependently prevents palmitate induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor dependent pathways in beta-cells. J Biol Chem, 279:8938–45
   PubMed Web of Science ®Google Scholar
• Lambeir AM, Durinx C, Scharpé S, De Meester I. (2003). Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci, 40:209–94
   PubMed Web of Science ®Google Scholar
• Lee YC, Nielsen JN. (2009). Regulation of beta cell replication. Molecular and Cellular Endocrinology, 297:18–27
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. (2008). Autophagy in the pathogenesis of disease. Cell, 132:27–42
   PubMed Web of Science ®Google Scholar
• Li L, Lili R, Hui Q, et al. (2008). Combination of GLP-1 and sodium butyrate promote differentiation of pancreatic progenitor cells into insulin-producing cells. Tissue Cell, 40:437–45
   PubMed Web of Science ®Google Scholar
• Madsen K, Knudsen LB, Agersoe H, et al. (2007). Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness. J Med Chem, 29:6126–32
   Google Scholar
• Maida A, Hansotia T, Longuet C, et al. (2009). Differential importance of glucosedependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice. Gastroenterology, 137:2146–57
   PubMed Web of Science ®Google Scholar
• Marchetti P, Del Guerra S, Marselli L, et al. (2004). Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab, 89:5535–41
   PubMed Web of Science ®Google Scholar
• Marchetti P, Dotta F, Lauro D, Purrello F. (2008). An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept, 146:4–11
   PubMedGoogle Scholar
• Marchetti P, Lupi R, Bugliani M, et al. (2009). Autophagy and the pancreatic beta-cell in human type 2 diabetes. Autophagy, 5:1055–6
   PubMed Web of Science ®Google Scholar
• Marchetti P, Lupi R, Bugliani M, et al. (2012). A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia, 55:3262–72
   PubMed Web of Science ®Google Scholar
• Marsh BJ, Soden C, Alarcón C, et al. (2007). Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine β-cells. Mol Endocrinol, 21:2255–69
   PubMed Web of Science ®Google Scholar
• Martin J, Hunt SL, Dubus P, et al. (2003). Genetic rescue of Cdk4 null mice restores pancreatic. β-cell proliferation but not homeostatic cell number. Oncogene, 22:5261–69
   Google Scholar
• Mayo KE, Miller LJ, Bataille D, et al. (2003). International union of pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev, 55:167–94
   Google Scholar
• McIntyre N, Holdsworth Cd, Turner Ds. (1964). New interpretation of oral glucose tolerance. Lancet, 2:20–1
   PubMed Web of Science ®Google Scholar
• Meier JJ, Bhushan A, Butler AE, et al. (2005). Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia, 48:2221–8
   PubMed Web of Science ®Google Scholar
• Meier JJ, Butler AE, Saisho Y, et al. (2008). Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes, 57:1584–94
   PubMed Web of Science ®Google Scholar
• Mojsov S, Heinrich G, Wilson IB, et al. (1986). Preproglucagon gene expression in pancreas and intestine diversifies at the level of posttranslational processing. J Biol Chem, 261:11880–9
   PubMed Web of Science ®Google Scholar
• Montrose-Rafizadeh C, Wang Y, Janczewski AM, et al. (1997). Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness. Mol Cell Endocrinol, 130:109–17
   PubMed Web of Science ®Google Scholar
• Mortensen K, Christensen LL, Holst JJ, Orskov C. (2003). GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept, 114:189–96
   PubMed Web of Science ®Google Scholar
• Nagaya M, Katsuta H, Kaneto H, et al. (2009). Adult mouse intrahepatic biliary epithelial cells induced in vitro to become insulin-producing cells. J Endocrinol, 201:37–47
   PubMed Web of Science ®Google Scholar
• Natalicchio A, De Stefano F, Orlando MR, et al. (2010). Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells. Endocrinology, 151:2019–29
   PubMed Web of Science ®Google Scholar
• Nauck MA, Heimesaat MM, Orskov C, et al. (1993). Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest, 91:301–7
   PubMed Web of Science ®Google Scholar
• Nauck MA. (2011). Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. Am J Med, 124:S3–18
   PubMed Web of Science ®Google Scholar
• Nir T, Melton DA, Dor Y. (2007). Recovery from diabetes in mice by β cell regeneration. J Clin Inv, 117:2553–61
   PubMed Web of Science ®Google Scholar
• Ogino J, Sakurai K, Yoshiwara K, et al. (2006). Insulin resistance and increased pancreatic β-cell proliferation in mice expressing a mutant insulin receptor (P1195L). J Endocrinol, 190:739–47
   PubMed Web of Science ®Google Scholar
• Okada T, Liew CW, Hu J, et al. (2007). Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA, 104:8977–82
   PubMed Web of Science ®Google Scholar
• Orskov C, Wettergren A, Holst JJ. (1996). Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scand J Gastroenterol, 31:665–70
   PubMed Web of Science ®Google Scholar
• Pandey UB, Nie Z, Batlevi Y, et al. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature, 447:859–63
   PubMed Web of Science ®Google Scholar
• Parsons JA, Brelje TC, Sorenson RL. (1992). Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology, 130:1459–66
   PubMed Web of Science ®Google Scholar
• Parsons JA, Bartke A, Sorensons RL. (1995). Number and size of islets of Langehans in pregnancy, human growth hormone-expressing transgenic and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology, 136:2013–21
   PubMed Web of Science ®Google Scholar
• Perfetti R, Zhou J, Doyle ME, Egan JM. (2000). Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology, 141:4600–5
   PubMed Web of Science ®Google Scholar
• Poitout V. (2013). Lipotoxicity impairs incretin signalling. Diabetologia, 56:231–3
   PubMed Web of Science ®Google Scholar
• Prentki M, Nolan CJ. (2006). Islet b cell failure in type 2 diabetes. J Clin Invest, 116:1802–12
   PubMed Web of Science ®Google Scholar
• Rane SG, Dubus P, Mettus RV, et al. (1999). Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta islet cell hyperplasia. Nat Genet, 22:44–52
   PubMed Web of Science ®Google Scholar
• Rhodes CJ. (2005). Type 2 diabetes – a matter of beta-cell life and death? Science, 307:380–84
   PubMed Web of Science ®Google Scholar
• Rieck S, Kaestner KH. (2010). Expansion of β-cell mass in response to pregnancy. Trends Endocrinol Metabol, 21:151–8
   PubMed Web of Science ®Google Scholar
• Rozengurt N, Wu SV, Chen MC, et al. (2006). Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol, 291:G792–802
   PubMed Web of Science ®Google Scholar
• Seeberger KL, Dufour JM, Shapiro AM, et al. (2006). Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest, 86:141–53
   PubMed Web of Science ®Google Scholar
• Simonsen L, Holst JJ, Deacon CF. (2006). Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. Diabetologia, 49:706–12
   PubMed Web of Science ®Google Scholar
• Stoffers DA, Kieffer TJ, Hussain MA, et al. (2000). Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX 1 and increase islet size in mouse pancreas. Diabetes, 49:741–8
   PubMed Web of Science ®Google Scholar
• Stoffers DA, Desai BM, DeLeon DD, Simmons RA. (2003). Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes, 52:734–40
   PubMed Web of Science ®Google Scholar
• Ta M, Choi Y, Atouf F, et al. (2006). The defined combination of growth factors controls generation of long-term-replicating islet progenitor-like cells from cultures of adult mouse pancreas. Stem Cells, 24:1738–49
   PubMed Web of Science ®Google Scholar
• Takeda Y, Fujita Y, Honjo J, et al. (2012). Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. Diabetologia, 55:404–12
   PubMed Web of Science ®Google Scholar
• Teta M, Long SY, Wartschow LM, et al. (2005). Very slow turnover of β-cells in aged adult mice. Diabetes, 54:2557–67
   PubMed Web of Science ®Google Scholar
• Teta M, Rankin MM, Long SY, et al. (2007). Growth and regeneration of adult Beta cells does not involve specialized progenitors. Dev Cell, 12:817–26
   PubMed Web of Science ®Google Scholar
• Thorel F, Népote V, Avril I, et al. (2010). Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature, 464:1149–54
   PubMed Web of Science ®Google Scholar
• Todorov I, Omori K, Pascual M, et al. (2006). Generation of human islets through expansion and differentiation of non-islet pancreatic cells discarded (pancreatic discard) after islet isolation. Pancreas, 32:130–8
   PubMed Web of Science ®Google Scholar
• Tourrel C, Bailbe D, Meile MJ, et al. (2001). Glucagon-like peptide-1 and exendin 4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes, 50:1562–70
   PubMed Web of Science ®Google Scholar
• Trümper A, Trümper K, Trusheim H, et al. (2001). Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol, 15:1559–70
   PubMed Web of Science ®Google Scholar
• Trümper A, Trümper K, Hörsch D. (2002). Mechanisms of mitogenic and antiapoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. J Endocrinol, 174:233–46
   PubMed Web of Science ®Google Scholar
• Trümper J, Ross D, Jahr H, et al. (2005). The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells. Diabetologia, 48:1534–40
   PubMed Web of Science ®Google Scholar
• Tschen SI, Dhawan S, Gurlo T, Bhushan A. (2009). Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes, 58:1312–20
   PubMed Web of Science ®Google Scholar
• Tsunekawa S, Yamamoto N, Tsukamoto K, et al. (2007). Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol, 193:65–74
   PubMed Web of Science ®Google Scholar
• Wang Q, Brubaker PL. (2002). Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia, 45:1263–73
   PubMed Web of Science ®Google Scholar
• Wang Q, Li L, Xu E, et al. (2004). Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia, 47:478–87
   PubMed Web of Science ®Google Scholar
• Westermark P, Wilander E. (1978). The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia, 15:417–21
   PubMed Web of Science ®Google Scholar
• Wettergren A, Pridal L, Wojdemann M, Holst JJ. (1998). Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans. Regul Pept, 77:83–7
   PubMed Web of Science ®Google Scholar
• Widenmaier SB, Ao Z, Kim SJ, et al. (2009a). Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide. J Biol Chem 284, 30372e30382
   Google Scholar
• Widenmaier SB, Sampaio AV, Underhill TM, McIntosh CH. (2009b). Noncanonical activation of Akt/protein kinase B in {beta}-cells by the incretin hormone glucosedependent insulinotropic polypeptide. J Biol Chem 284, 10764e10773
   Google Scholar
• Widenmaier SB, Kim SJ, Yang GK, et al. (2010). A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control. PLoS One [Online] Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0009590 [last accessed 9 Mar 2010]
   Google Scholar
• Williams A, Jahreiss L, Sarkar S, et al. (2006). Aggregate-prone proteins are cleared from the cytosol by autophagy: herapeutic implications. Curr Top Dev Biol, 76:89–101
   PubMed Web of Science ®Google Scholar
• Xu G, Stoffers DA, Habener JF, Bonner-Weir S. (1999). Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes, 48:2270–6
   PubMed Web of Science ®Google Scholar
• Xu X, D'Hoker J, Stangé G, et al. (2008). Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell, 132:197–207
   PubMed Web of Science ®Google Scholar
• Yoon KH, Ko SH, Cho JH, et al. (2003). Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes in Korea. J Clin Endocrinol Metab, 88:2300–8
   PubMed Web of Science ®Google Scholar
• Yusta B, Baggio LL, Estall JL, et al. (2006). GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab, 4:391–406
   PubMed Web of Science ®Google Scholar
• Zhang X, Gaspard JP, Mizukami Y, et al. (2005). Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes, 54:712–19
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang X, Pineyro MA, Egan JM. (1999). Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulinproducing cells. Diabetes, 48:2358–66
   PubMed Web of Science ®Google Scholar
• Zhou J, Pineyro MA, Wang X, et al. (2002). Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors. J Cell Physiol, 192:304–14
   PubMed Web of Science ®Google Scholar
• Zhou Q, Brown J, Kanarek A, et al. (2008). In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature, 455:627–32
   PubMed Web of Science ®Google Scholar
• Zulewski H, Abraham EJ, Gerlach MJ, et al. (2001). Multipotential nestinpositive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes, 50:521–33
   PubMed Web of Science ®Google Scholar
• Zunz E, La Barre J. (1929). Contributiona a l’etude des variations physiologiques de la secretion interne du pancreas. relations entre les secretions externe et interne du pancreas. Arch Int Physiol Biochim, 31:20–44
   Google Scholar